Nombre del producto:Quinoxaline, 2,3-bis(bromomethyl)-, 1,4-dioxide

IUPAC Name:2,3-bis(bromomethyl)quinoxaline-1,4-diium-1,4-bis(olate)

CAS:18080-67-6
Fórmula molecular:C10H8Br2N2O2
Pureza:95%+
Número de catálogo:CM429604
Peso molecular:347.99

Unidad de embalaje Stock disponible Precio($) Cantidad
CM429604-10mg 1-2 Weeks ưNJ
CM429604-50mg 3-4 Weeks ƓȎʼn
CM429604-100mg 3-4 Weeks ǤʼnŢ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :18080-67-6
Fórmula molecular:C10H8Br2N2O2
Punto de fusión:-
Código de sonrisas:[O-][N+]1=C2C=CC=CC2=[N+]([O-])C(CBr)=C1CBr
Densidad:
Número de catálogo:CM429604
Peso molecular:347.99
Punto de ebullición:
Nº Mdl:MFCD00186742
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.